Filtered By:
Infectious Disease: SARS
This page shows you your search results in order of date. This is page number 2.
Order by Relevance | Date
Total 1917 results found since Jan 2013.
Asthma in elderly and coronavirus disease 2019
Once the first wave of severe acute respiratory syndrome coronavirus 2 novel coronavirus disease subsided, the attempt was made to investigate both short- and long-term potential consequences, especially in high-risk patient cohorts including those after prolonged hospitalization and intensive therapy.1 Symptoms persisting 3 to 6 months after acute coronavirus disease 2019 (COVID-19) (post –COVID-19 syndrome) have been described.2-5 Currently, there is a lack of information on post–COVID-19 consequences in elderly patients with asthma.
Source: Annals of Allergy, Asthma and Immunology - August 7, 2023 Category: Allergy & Immunology Authors: Sergey N. Avdeev, Viliya V. Gaynitdinova, Anna A. Pozdnakova, Svetlana Yu Chikina, Karina A. Kosobokova Tags: Letters Source Type: research
Did the coronavirus disease 2019 pandemic change asthma prevalence?
Circulating coronaviruses have been associated with asthma exacerbations; however, early in the coronavirus disease 2019 pandemic, asthma exacerbations decreased.1 Similarly, other pandemic coronaviruses (sever acute respiratory syndrome [SARS] and Middle East Respiratory Syndrome) have not been associated with asthma exacerbations.2 However, as SARS coronavirus 2 (SARS-CoV-2) becomes less virulent and more like the circulating non-pandemic coronaviruses, there have been reports that asthma exacerbations are increasing.
Source: Annals of Allergy, Asthma and Immunology - August 1, 2023 Category: Allergy & Immunology Authors: Rebecca Koenigsberg, Mitchell H. Grayson Tags: Editorial Source Type: research
Immune Profiling of SARS-CoV-2; What We Know and What We Don't Know
Iran J Allergy Asthma Immunol. 2023 Jun 16;22(3):217-232. doi: 10.18502/ijaai.v22i3.13050.ABSTRACTCoronavirus disease 2019 (COVID-19), described as World War 3, is the current worldwide health challenge and nearly all countries have so far faced this disaster. There is still no cure because of the complicated pathogenesis, however, there are several studies on track investigating different aspects of the immune response to the virus. In this review, we will provide an overview of recent investigations that have analyzed immune cells in patients with COVID-19. We will then discuss the differences in immune profiles between ...
Source: Iranian Journal of Allergy, Asthma and Immunology - July 31, 2023 Category: Allergy & Immunology Authors: Mahshid Zohouri Atri Ghods Mina Roshan Zamir Fazel Shokri Abbas Ghaderi Source Type: research
